Incannex Healthcare Limited
IXHL · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | 0.01 | -0.07 | 0.05 |
| FCF Yield | -13.90% | 0.00% | -21.09% | 0.00% |
| EV / EBITDA | 0.19 | 0.00 | -4.35 | 0.00 |
| Quality | ||||
| ROIC | -91.82% | 0.00% | -118.42% | 0.00% |
| Gross Margin | 100.00% | 0.00% | 100.00% | 100.00% |
| Cash Conversion Ratio | 0.03 | 1.34 | 0.56 | 0.40 |
| Growth | ||||
| Revenue 3-Year CAGR | 579,776.31% | -18.48% | -36.17% | -39.13% |
| Free Cash Flow Growth | 0.00% | 0.00% | 0.00% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | 0.38 | 0.00 | -0.22 | 0.00 |
| Interest Coverage | -94.93 | -37.90 | -29.26 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 6,249.85 | 0.00 | 31,799.94 | 0.00 |